Abstract Details

Title The Utility of the ID Migraine in Migraine Diagnosis in Calabar, Nigeria

Topic Headache

Presentation(s) P11 - Poster Session 11 (8:00 AM-9:00 AM)

Poster/Presentation
Number 7-012

Objective This study aimed to evaluate the accuracy of ID migraine, a 3-item tool, for migraine diagnosis in the Calabar setting of south-eastern Nigeria, to determine its relevance to clinical practice in our locality.

Background Under-recognition and consequent mistreatment of migraine highlight the importance of quick and easier tools for migraine diagnosis. The ID migraine, a 3-item migraine diagnosis tool, fits the description of such a rapid tool. Validation of the ID migraine questionnaire in a given locality is beneficial because of the varying socio-cultural dynamics that influence the concept of wellness and illness experience.

Design/Methods

In this cross-sectional study, we compared the ID migraine with the International Headache Society criteria, used as the gold standard, in migraine diagnosis on persons with recurrent headaches, recruited from a pool of 220 clinical students in the University of Calabar, Nigeria. We computed the sensitivity, specificity, positive predictive and negative predictive values of the ID migraine in the locality from the obtained data.

Results Fifty-one persons who had recurrent headaches from the pool of students, comprising 25 (49%) males and 26 (51%) females, completed the study. The mean age of the participants was 24.2 years ± 4.6. The derived sensitivity, specificity, positive predictive and negative predictive values of the ID migraine were 69.2%, 63.1%, 39.1% and 85.7%, (kappa = 0.26; P = 0.043).

Conclusions The ID migraine tool had moderate sensitivity and specificity in our study and a low level of agreement with the gold standard. Its usefulness may be more in excluding migraine in persons with recurrent headaches.

Authors/Disclosures
Sidney Oparah, MD (UCTH Calabar) PRESENTER	Dr. Oparah has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis . Dr. Oparah has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for MICRO LABS.
	No disclosure on file
	No disclosure on file
Ozomma I. Simon, MBBS (University of Calabar Teaching Hospital)	Dr. Simon has nothing to disclose.

��ɫ��

��ɫ��